Ledger.Open graph →
SEC Form D · filed November 24, 2025

Arpeggio Biosciences, Inc

Offering
$35.3M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
BOULDER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Laura G. Norris · BOULDER, COExecTimothy G. Read · BOULDER, COExecJoseph G. Azofeifa · BOULDER, COExec · DirectorTimothy G. Read · BOULDER, COExecJoseph G. Azofeifa · BOULDER, COExec · DirectorLaura G. Norris · BOULDER, COExecDavid G. Allison · BOULDER, CODirectorMira G. Chaurushiya · BOULDER, CODirectorSamuel G. Kintz · BOULDER, CODirectorAaron G. Royston · BOULDER, CODirectorMatthew Joen · Denver, NCExecJonathon Blackwell · New York, NYExecChris E. Elkins · Fayetteville, ARExec · DirectorDavid G. Allison · BOULDER, CODirectorMira G. Chaurushiya · BOULDER, CODirectorSamuel G. Kintz · BOULDER, CODirectorAaron G. Royston · BOULDER, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗